Mosconi et al. corroborated these findings in their investigation of levels of PD-L1, PD-L2, PD-1, and CTLA-4, as well as markers of tumor-infiltrating lymphocytes and dendritic cells in 36 ACC samples [79]. The gene discussed is PDCD1LG2; the disease is adrenal cortex carcinoma.